Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

A 56620

Known as: A-56620 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1987
Highly Cited
1987
Most antibacterial agents do not affect human lymphocyte function, but a few are inhibitory. In contrast, a pronounced increase… Expand
1986
1986
The in vitro activities of two new aryl-fluoroquinolones (A-56619 and A-56620) were compared with those of ciprofloxacin… Expand
Highly Cited
1986
Highly Cited
1986
  • S. Smith
  • Antimicrobial Agents and Chemotherapy
  • 1986
  • Corpus ID: 25737176
Seven quinolone antibiotics were tested against 115 isolates of methicillin-resistant Staphylococcus aureus. The MICs for 90% of… Expand
Highly Cited
1986
Highly Cited
1986
The in vitro antibacterial potencies of A-56619 and A-56620, two new aryl-fluoroquinolones, were compared with the potency of… Expand
1986
1986
The in vitro activity of difloxacin (A-56619) and A-56620, two new aryl-difluoroquinolones, was decreased by magnesium at 9 mM… Expand
Highly Cited
1986
Highly Cited
1986
The in-vitro antibacterial activity of nalidixic acid and the 4-quinolones, ciprofloxacin, norfloxacin, enoxacin, ofloxacin… Expand
1986
1986
A-56619 and A-56620 are two new aryl-fluoroquinolones which are as potent as or more potent than norfloxacin when administered… Expand
1986
1986
Aryl-fluoroquinolone derivatives A-56619 (difloxacin) and A-56620 were found to inhibit human peripheral blood mononuclear cell… Expand
1986
1986
The in vitro activities of two new carboxyquinolones, A-56619 (difloxacin) and A-56620, were compared with those of ciprofloxacin… Expand
Highly Cited
1985
Highly Cited
1985
The in vitro activities of two new quinolone antimicrobial agents, A-56619 and A-56620, were compared with those of norfloxacin… Expand